loading page

The Gut-Brain Axis in Neurodevelopmental Disorders:  Mechanistic Insights, Clinical Implications, and Public Health Strategies
  • +9
  • Nicholas A. Kerna,
  • Dabeluchi C. Ngwu,
  • Chukwuemeka O. Keke,
  • Kevin D. Pruitt,
  • Frank O. Olaniru,
  • Breanna M. Jomsky,
  • Bafford N. Nwafor,
  • N.D. Victor Carsrud,
  • John V. Flores,
  • Hilary M. Holets,
  • Devin McKee,
  • Joseph Anderson II
Nicholas A. Kerna
Independent Global Medical Researchers Consortium™; First InterHealth Group, Thailand

Corresponding Author:drkerna@gmail.com

Author Profile
Dabeluchi C. Ngwu
FMC Umuahia with King Abdullah Hospital, Bisha, Saudi Arabia; Earthwide Surgical Missions, Nigeria
Chukwuemeka O. Keke
Federal Medical Centre, Umuahia, Abia State, Nigeria
Kevin D. Pruitt
Kemet Medical Consultants, USA; PBJ Medical Associates, LLC, USA
Frank O. Olaniru
Department of Acute Medicine, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK
Breanna M. Jomsky
Lake Erie College of Osteopathic Medicine, USA
Bafford N. Nwafor
No Affiliation Declared
N.D. Victor Carsrud
Lakeline Wellness Center, USA
John V. Flores
Orange Partners Surgicenter, USA
Hilary M. Holets
Orange Partners Surgicenter, USA
Devin McKee
Bastyr University, College of Naturopathic Medicine, USA
Joseph Anderson II
International Institute of Original Medicine, USA

Abstract

The integration of gut microbiota research into the understanding and treatment of neurodevelopmental disorders has profound implications for both clinical practice and public health. The microbial community’s influence on neural development through mechanisms such as microbial metabolites, immune regulation, and gene expression underscores the complexity of neurodevelopmental disorders like autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD). As research continues to unravel the intricate relationship between gut microbiota and brain function, innovative therapeutic interventions, including probiotics, prebiotics, and fecal microbiota transplantation, hold potential to improve symptoms and outcomes. However, the safety and long-term effectiveness of these therapies remain critical areas for future investigation. Advances in diagnostic tools and personalized medicine, which incorporate microbial biomarkers, offer exciting prospects for early detection and tailored treatments, ultimately improving the quality of life for individuals with neurodevelopmental disorders. Continued interdisciplinary collaboration is essential for translating these findings into practical solutions that address the underlying mechanisms of these complex disorders. This review highlights the critical role of gut microbiota in neurodevelopmental disorders, emphasizing the importance of microbial metabolites, immune regulation, and genetic interactions in shaping brain development.